爱沙尼亚注射吸毒人群中艾滋病毒、乙型肝炎病毒和丙型肝炎病毒的监测：用于公共卫生监测的注射器检测的敏感性和特异性
Surveillance of HIV, hepatitis B virus, and hepatitis C virus in an estonian injection drug-using population: sensitivity and specificity of testing syringes for public health surveillance.
作者信息
Uuskula Anneli, Heimer Robert, Dehovitz Jack, Fischer Krista, McNutt Louise-Anne
机构信息
Department of Public Health, University of Tartu, Estonia.
出版信息
J Infect Dis. 2006 Feb 1;193(3):455-7. doi: 10.1086/499436. Epub 2005 Dec 22.
Abstract
Surveillance of bloodborne infections among injection drug users (IDUs) can be accomplished by determining the presence of pathogen markers in used syringes. Parallel testing of returned syringes and venous blood from IDUs was conducted to detect antibodies to human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV). Syringe surveillance for HIV yielded a sensitivity and specificity of 92% and 89%, respectively, and provided a reasonable estimate of the prevalence of HIV among participants. Because sensitivity for HBV (34%) and HCV (55%) was low, syringe testing may be useful for surveillance of hepatitis over time but not for estimation of prevalence.
摘要
通过检测用过的注射器中病原体标志物，可以实现对注射吸毒者（IDU）血源感染的监测。对IDU归还的注射器和静脉血进行平行检测，以检测针对人类免疫缺陷病毒（HIV）、乙型肝炎病毒（HBV）和丙型肝炎病毒（HCV）的抗体。HIV的注射器监测敏感性和特异性分别为92%和89%，并为参与者中HIV的流行率提供了合理估计。由于HBV（34%）和HCV（55%）的敏感性较低，注射器检测可能有助于长期监测肝炎，但不适用于估计流行率。
相似文献
1
Surveillance of HIV, hepatitis B virus, and hepatitis C virus in an estonian injection drug-using population: sensitivity and specificity of testing syringes for public health surveillance.
J Infect Dis. 2006 Feb 1;193(3):455-7. doi: 10.1086/499436. Epub 2005 Dec 22.
2
Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
Arch Virol. 2015 Apr;160(4):929-36. doi: 10.1007/s00705-014-2311-0. Epub 2015 Jan 24.
3
Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
BMC Public Health. 2020 Jun 3;20(1):851. doi: 10.1186/s12889-020-09012-w.
4
Prevalence of Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus Among Homeless and Nonhomeless United States Veterans.
Clin Infect Dis. 2017 Jul 15;65(2):252-258. doi: 10.1093/cid/cix295.
5
Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
J Infect Dev Ctries. 2013 Jun 15;7(6):453-67. doi: 10.3855/jidc.2965.
6
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: A cross-sectional study.
Sci Rep. 2019 Apr 18;9(1):6292. doi: 10.1038/s41598-019-42810-w.
7
Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
J Urban Health. 2008 May;85(3):309-22. doi: 10.1007/s11524-008-9271-1. Epub 2008 Mar 14.
8
Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
Ig Sanita Pubbl. 2005 Sep-Oct;61(5):435-50.
9
Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
Eur J Epidemiol. 1998 Sep;14(6):555-61. doi: 10.1023/a:1007410707801.
10
High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia.
Int J STD AIDS. 2007 Jan;18(1):41-6. doi: 10.1258/095646207779949907.
引用本文的文献
1
High levels of used syringe use and unsafe sex among people who inject drugs in Kumasi, Ghana: an urgent call for a comprehensive harm reduction approach.
Harm Reduct J. 2021 Jun 10;18(1):62. doi: 10.1186/s12954-021-00510-7.
2
Implementing an Updated "Break the Cycle" Intervention to Reduce Initiating Persons into Injecting Drug Use in an Eastern European and a US "opioid epidemic" Setting.
AIDS Behav. 2019 Sep;23(9):2304-2314. doi: 10.1007/s10461-019-02467-y.
3
T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use.
Viral Immunol. 2016 Oct;29(8):464-470. doi: 10.1089/vim.2016.0057. Epub 2016 Aug 26.
4
Developing an adherence support intervention for patients on antiretroviral therapy in the context of the recent IDU-driven HIV/AIDS epidemic in Estonia.
AIDS Care. 2013;25(7):863-73. doi: 10.1080/09540121.2013.764393. Epub 2013 Feb 7.
5
Estonia at the threshold of the fourth decade of the AIDS era in Europe.
AIDS Res Hum Retroviruses. 2011 Aug;27(8):841-51. doi: 10.1089/aid.2010.0223. Epub 2011 Jan 11.
本文引用的文献
1
Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group.
MMWR Recomm Rep. 2001 Jul 27;50(RR-13):1-35; quiz CE1-7.
2
Estimating the prevalence of syringe-borne and sexually transmitted diseases among injection drug users in St Petersburg, Russia.
Int J STD AIDS. 2003 Oct;14(10):697-703. doi: 10.1258/095646203322387965.
3
HIV in central and eastern Europe.
Lancet. 2003 Mar 22;361(9362):1035-44. doi: 10.1016/S0140-6736(03)12831-0.
4
The role of injection drug use in the emergence of Human Immunodeficiency Virus infection in Estonia.
Int J Infect Dis. 2002 Mar;6(1):23-7. doi: 10.1016/s1201-9712(02)90131-1.
5
Hepatitis in used syringes: the limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens.
J Infect Dis. 1996 Apr;173(4):997-1000. doi: 10.1093/infdis/173.4.997.
6
HIV DNA and antibodies in syringes from injecting drug users: a comparison of detection techniques.
AIDS. 1993 Jul;7(7):925-31. doi: 10.1097/00002030-199307000-00004.
7
HIV incidence among needle exchange participants: estimates from syringe tracking and testing data.
J Acquir Immune Defic Syndr (1988). 1994 Feb;7(2):182-9.
8
A circulation theory of needle exchange.
AIDS. 1994 May;8(5):567-74. doi: 10.1097/00002030-199405000-00001.
9
Syringe HIV seroprevalence and behavioural and demographic characteristics of intravenous drug users in Sydney, Australia, 1987.
AIDS. 1988 Oct;2(5):373-7. doi: 10.1097/00002030-198810000-00007.
10
HIV prevalence among intravenous drug users: model-based estimates from New Haven's legal needle exchange.
J Acquir Immune Defic Syndr (1988). 1992;5(2):163-9.
Zotero 插件